ofloxacin otic solution 0.3%
Drugofloxacin otic solution 0.3% instilled twice a day for seven days
NCT Number: NCT00781521
This was a pilot study to determine the safety and effectiveness of a twice daily, seven-day dosing regimen in acute, pediatric, otitis media in children with tympanostomy tubes. The currently approved regimen is twice daily for 10 days.
Looking for future studies?
Notify Me6 month–12 year
All sexes
Interventional
Phase 3
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ofloxacin otic solution 0.3% instilled twice a day for seven days
Time frame: 7 days
Time frame: 7 days
Time frame: 7 days
Time frame: 7 days
Time frame: 7 days
Time frame: 7 days
Daiichi Sankyo
Industry
A Pilot, Multicenter, Open Label, Non Comparative Study of the Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media Twice Daily for Seven Days in Children With Tympanostomy Tubes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00419380
Ear Diseases, Otitis
Denver, Colorado, United States
View Trial DetailsNCT06731660
Antimicrobial Stewardship, Ear Diseases
Wellesley, Massachusetts, United States
View Trial DetailsNCT02972281
Antibody Deficiency, Bacterial Infections
Armentières, France
View Trial DetailsNCT05127161
Acute Respiratory Tract Infection, Acute Sinusitis
Plantation, Florida, United States
View Trial Details